US 11845990
Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
granted A61KA61K31/16A61P
Quick answer
US patent 11845990 (Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype) held by VANDA PHARMACEUTICALS INC. expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/16, A61P, A61P25/00, A61P25/20